AI in Biotech Research: Boon or Bane?
Philip Crowley
November 29, 2024
Is Artificial Intelligence a Boon Or a Bane? Just a few years ago, discussions about artificial intelligence (“AI”) were mostly
Is Artificial Intelligence a Boon Or a Bane? Just a few years ago, discussions about artificial intelligence (“AI”) were mostly
How AI Is Shaping Life Sciences: Challenges, Risks and Future Prospects Artificial intelligence (“AI”) has become a buzzword—almost every article,
Cybersecurity Challenges in Biotech: Why Your Data is a Prime Target In the first quarter of 2024, weekly cyberattacks against
Shaping Tomorrow: Trends in Biopharmaceutical Manufacturing & FDA Innovations We recently attended an insightful seminar on biotech manufacturing that we’d
The Rise of AI in Life Sciences: Potential and Real Risks Artificial intelligence (AI) is a hot topic. Every article,
Understanding RSV: A Danger to Our Most Vulnerable Populations Great news for the prevention of respiratory syncytial virus (“RSV”) infections!
The BioNJ 31st Annual Dinner Meeting and Innovation Celebration, held on February 8, 2024, was a significant event that showcased
Bio NJ has some tremendous opportunities for C-suite executives at life sciences companies. Bio NJ has established a networking and
Here’s a great opportunity for those interested in biomedical research and entrepreneurship. The Biomedical Engineering Department at Stevens Institute of Technology
Orphan drug development is a crucial and complex area of pharmaceutical research. It’s dedicated to creating treatments for rare diseases.
Losing one’s sight is one of the cruelest types of disabilities. We depend on that sense for so much of
The realm of medical devices has seen remarkable advancements in 2023. Innovators need to be aware of these advancements to
Key Highlights: · Strategic Shift: CRISPR Therapeutics is pivoting from cancer drug development to cell-based medicines for autoimmune
It’s not just your hometown physician’s travel bag anymore! In the dynamic field of life sciences, cell and gene therapy
One of the features that excites me about representing life sciences and other technology innovators is the impact they can
We live in an extraordinary time. It’s a time where technology in life sciences is peeling back the curtain on
Stevens Institute of Technology (“Stevens”) has announced some great results impacting cancer therapies. In this note, I’ll describe Crowley Law is
A new investigational therapy from Celldex Therapeutics Inc. in Hampton, New Jersey provides the promise of substantial relief from “hives”,
Diabetes can be a silent, slow killer. Over time, its detrimental effects on the body can result in life-altering complications.
Come hear a distinguished leader of the pharmaceutical industry speak about the impact of technology on the biopharmaceutical industry. Dr.
Do you think of Arnold Schwarzenegger in the film “Terminator” whenever we talk about “artificial intelligence”?! It really doesn’t have
The Impact of Real-World Evidence (RWE) on Drug Testing & FDA Approval The landscape of drug development is undergoing a
There’s no stopping Mother Nature when she gets going. The striking force of a tornado recently tore through a Pfizer
Securing Your Intellectual Property in the Age of Discovery Is artificial intelligence (AI) a boon or bane, or perhaps a bit
Recently proposed Federal legislation would have a very damaging effect on the biotech industry. Those are the conclusions of a recent